Cargando…
Platelet activating factor-induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD-2)
Autores principales: | Mullol, Joaquim, Muñoz-Cano, Rosa, Torres-Atencio, I, Ainsua, E, Martin, M, Sanchez-Lopez, J, Bartra, Joan, Picado, Cesar, Valero, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716519/ http://dx.doi.org/10.1186/2045-7022-3-S2-O6 |
Ejemplares similares
-
Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design
por: Muñoz-Cano, Rosa, et al.
Publicado: (2013) -
MrgX2-mediated internalization of LL-37 and degranulation of human LAD2 mast cells
por: Murakami, Taisuke, et al.
Publicado: (2018) -
Prostaglandin E(2) Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP(2) and EP(4)
por: Torres-Atencio, Ivonne, et al.
Publicado: (2014) -
Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium
por: Grace, Shane A, et al.
Publicado: (2017) -
SNARE complex-mediated degranulation in mast cells
por: Woska, Joseph R, et al.
Publicado: (2012)